We found that SLC2A3, a key transporter in the glycolysis, showed a significant positive correlation with UBD in the network, suggesting that UBD may enhance glucose uptake by upregulating the expression of these transporters, thereby providing sufficient energy for tumor cells. This evidence concerns the gene SLC2A3 and neoplasm.